G-Protein Coupled Receptors Engage the Mammalian Hippo pathway through F-Actin F-Actin, assembled in response to Galpha
The Hippo pathway, a cascade of protein kinases that inhibits the oncogenic transcriptional coactivators YAP and TAZ, was discovered in Drosophila as a major determinant of organ size in development. Known modes of regulation involve surface proteins that mediate cell-cell contact or determine epith...
Saved in:
Published in | BioEssays Vol. 35; no. 5; pp. 430 - 435 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
01.03.2013
|
Online Access | Get full text |
Cover
Loading…
Summary: | The Hippo pathway, a cascade of protein kinases that inhibits the oncogenic transcriptional coactivators YAP and TAZ, was discovered in Drosophila as a major determinant of organ size in development. Known modes of regulation involve surface proteins that mediate cell-cell contact or determine epithelial cell polarity which, in a tissue specific manner, use intracellular complexes containing FERM domain and actin-binding proteins to modulate the kinase activities or directly sequester YAP. Unexpectedly, recent work demonstrates that GPCRs, especially those signaling through Galpha
12/13
such as the Protease Activated Receptor PAR1, cause potent YAP dephosphorylation and activation. This response requires active RhoA GTPase and increased assembly of filamentous (F-)actin. Morever, cell architectures that promote F-actin assembly per se also activate YAP by kinase-dependent and independent mechanisms. These findings unveil the ability of GPCRs to activate the YAP oncogene through a newly recognized signaling function of the actin cytoskeleton, likely to be especially important for normal and cancerous stem cells. |
---|---|
ISSN: | 0265-9247 1521-1878 |
DOI: | 10.1002/bies.201200163 |